Idenix Pharmaceuticals announces job cuts as a result of strategic restructuring


Idenix Pharmaceuticals (IDIX) announces plans to reduce its workforce by around 15 positions in connection with the strategic restructuring of its operations at its headquarters in Cambridge, Massachusetts.

The reduction is part of an overall effort to improve operational efficiencies and outsource certain research and development functions, and will occur in the current quarter.

As a result, it expects to incur between $1M and $2M in one-time employee severance benefit charges and around $1M and $2M in non-cash stock compensation expense, but should result in annualized savings of approximately $2M to $3M.

The company says it's continuing to explore additional cost saving initiatives.

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs